Tomas Jan Heyman
Director/Miembro de la Junta en LEGEND BIOTECH CORPORATION .
Fortuna: 1 M $ al 31/12/2024
Perfil
Tomas Jan Heyman is currently the Chief Executive Officer at Interlaken Therapeutics, Inc. He is also an Independent Director at Exelixis, Inc., OptiNose, Inc., Legend Biotech Corp., Akero Therapeutics, Inc., and Invivyd, Inc. In addition, he serves as a Director at Interuniversitair Micro-Electronica Centrum VZW.
Previously, Mr. Heyman held the position of Chairman & Chief Executive Officer at Janssen Pharmaceutica NV from 2008 to 2016.
He was also a Non-Executive Chairman at Venatorx Pharmaceuticals, Inc. in 2023 and 2024.
He has served as a Director at CVRx, Inc. and the International Biomedical Research Alliance.
Additionally, he was an Independent Director at Xilio Therapeutics, Inc. from 2022 to 2024.
Mr. Heyman has a background in business development, having been the Global Head-Business Development at Johnson & Johnson from 1992 to 2015.
He has also held positions at Crucell NV, Johnson & Johnson Innovation - JJDC, Inc., and Ortho Pharmaceutical Corp.
Mr. Heyman obtained his graduate degree from Katholieke Universiteit Leuven and the University of Antwerp.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
EXELIXIS, INC.
0,01 % | 31/05/2024 | 37 014 ( 0,01 % ) | 1 M $ | 31/12/2024 |
31/12/2023 | 4 070 ( 0 % ) | 66 219 $ | 31/12/2024 | |
AKERO THERAPEUTICS, INC.
-.--% | 08/06/2024 | 0 ( -.--% ) | - $ | 31/12/2024 |
XILIO THERAPEUTICS INC
-.--% | 15/04/2024 | 0 ( -.--% ) | - $ | 31/12/2024 |
INVIVYD, INC.
-.--% | 22/03/2024 | 0 ( -.--% ) | - $ | 31/12/2024 |
OPTINOSE, INC.
-.--% | 06/06/2024 | 0 ( -.--% ) | - $ | 31/12/2024 |
Cargos activos de Tomas Jan Heyman
Empresas | Cargo | Inicio |
---|---|---|
AKERO THERAPEUTICS, INC. | Director/Miembro de la Junta | 09/06/2020 |
OPTINOSE, INC. | Director/Miembro de la Junta | 01/12/2020 |
INVIVYD, INC. | Director/Miembro de la Junta | 01/06/2021 |
LEGEND BIOTECH CORPORATION | Director/Miembro de la Junta | 02/08/2022 |
EXELIXIS, INC. | Director/Miembro de la Junta | 31/05/2023 |
Interlaken Therapeutics, Inc. | Director Ejecutivo | - |
Interuniversitair Micro-Electronica Centrum VZW
![]() Interuniversitair Micro-Electronica Centrum VZW Miscellaneous Commercial ServicesCommercial Services Interuniversitair Micro-Electronica Centrum VZW, also known as Imec, is a Belgian business accelerator. The non-profit company is based in Leuven, BE and has subsidiaries in the United States, Taiwan, India, Netherlands, and Belgium. Imec.istart is their main program, which helps startups grow and succeed. The Belgian company was founded in 1984 and has been led by CEO Luc van den Hove since then. | Director/Miembro de la Junta | 27/04/2012 |
Antiguos cargos conocidos de Tomas Jan Heyman.
Empresas | Cargo | Fin |
---|---|---|
XILIO THERAPEUTICS, INC. | Director/Miembro de la Junta | 13/06/2024 |
Venatorx Pharmaceuticals, Inc.
![]() Venatorx Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Venatorx Pharmaceuticals, Inc. develops novel anti-infective agents to address the threat of antibiotic resistance. It offers antibiotic resistant bacteria and Carbapenem-resistant Enterobacteriaceae a family of gram-negative bacteria that are resistant to all known ?-lactam antibiotics, including penicillins, cephalosporins, monobactams, and carbapenems. The company was founded by Christopher J. Burns, Luigi Xerri, and Daniel Pevear in 2010 and is headquartered in Malvern, PA. | Presidente | 16/05/2024 |
░░░░░░░ ░░░░░░░░░░░░░ ░░ | ░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░ ░░░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ | - |
Formación de Tomas Jan Heyman.
Katholieke Universiteit Leuven | Graduate Degree |
University of Antwerp | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 8 |
---|---|
CVRX, INC. | Health Technology |
AKERO THERAPEUTICS, INC. | Health Technology |
OPTINOSE, INC. | Health Technology |
INVIVYD, INC. | Health Technology |
JOHNSON & JOHNSON | Health Technology |
LEGEND BIOTECH CORPORATION | Health Technology |
XILIO THERAPEUTICS, INC. | Health Technology |
EXELIXIS, INC. | Health Technology |
Empresas privadas | 8 |
---|---|
Crucell NV
![]() Crucell NV Pharmaceuticals: MajorHealth Technology Crucell NV develops, produces and markets vaccines, proteins and antibodies that prevent and treat infectious diseases. It focuses in the research & development of innovative immunization candidates to fight against tuberculosis, malaria, HIV/AIDS, influenza, rabies, polio and several other diseases which are the global health problems. The firms prod8ucts include Quinvaxem, Epaxal, Hepavax-Gene, Vivotif and Dukoral against paediatric, respiratory and travel or endemic infections. The company was founded by Domenico Valerio on October 9, 2000 and is headquartered in Leiden, Netherlands. | Health Technology |
Johnson & Johnson Innovation - JJDC, Inc.
![]() Johnson & Johnson Innovation - JJDC, Inc. Investment ManagersFinance Johnson & Johnson Innovation JJDC Inc (Johnson & Johnson Innovation JJDC) is a venture capital subsidiary of Johnson & Johnson founded in 1973. The firm is headquartered in New Brunswick, New Jersey. | Finance |
International Biomedical Research Alliance
![]() International Biomedical Research Alliance Miscellaneous Commercial ServicesCommercial Services The International Biomedical Research Alliance supports the NIH Oxford-Cambridge Scholars Program and associated global Ph.D. and M.D./Ph.D. training programs based in the Intramural Research Program of the National Institutes of Health. The company was founded in 2005 and is headquartered in Bethesda, MD. | Commercial Services |
Janssen Pharmaceutica NV
![]() Janssen Pharmaceutica NV Pharmaceuticals: MajorHealth Technology Janssen Pharmaceutica NV engages in the development of medical solutions. It offers research and development services in the field of mental illness, neurological disorders, anesthesia, analgesia, gastrointestinal disorders, fungal infection, allergies and cancer. The firms products include Zytiga, Caelyx, Dacogen, Edurant, Fentanyl-Janssen, Intelence, Leustatin, , Pariet, and Reminyl. The company was founded in 1953 by Paul Janssen and is headquartered in Beerse, Belgium. | Health Technology |
Interuniversitair Micro-Electronica Centrum VZW
![]() Interuniversitair Micro-Electronica Centrum VZW Miscellaneous Commercial ServicesCommercial Services Interuniversitair Micro-Electronica Centrum VZW, also known as Imec, is a Belgian business accelerator. The non-profit company is based in Leuven, BE and has subsidiaries in the United States, Taiwan, India, Netherlands, and Belgium. Imec.istart is their main program, which helps startups grow and succeed. The Belgian company was founded in 1984 and has been led by CEO Luc van den Hove since then. | Commercial Services |
Interlaken Therapeutics, Inc. | |
Ortho Pharmaceutical Corp. | |
Venatorx Pharmaceuticals, Inc.
![]() Venatorx Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Venatorx Pharmaceuticals, Inc. develops novel anti-infective agents to address the threat of antibiotic resistance. It offers antibiotic resistant bacteria and Carbapenem-resistant Enterobacteriaceae a family of gram-negative bacteria that are resistant to all known ?-lactam antibiotics, including penicillins, cephalosporins, monobactams, and carbapenems. The company was founded by Christopher J. Burns, Luigi Xerri, and Daniel Pevear in 2010 and is headquartered in Malvern, PA. | Commercial Services |
- Bolsa de valores
- Insiders
- Tomas Jan Heyman